BioSpace News Archive

US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at the World Vaccine Congress Washington 2022 in Washington, D.C. on Wednesday, April 20, 2022 , at 3:25 p.m. ET.

Cyteir Therapeutics, Inc. will host a virtual R&D Day on April 26, 2022 starting at 8:30 a.m. ET.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, announced today that it will report results for first quarter ended March 31, 2022.

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), today announced its participation in the upcoming panel and fireside chat at the Chardan Genetic Medicines and Cell Therapy Manufacturing Summit.

Amoy Diagnostics Co., Ltd (AmoyDx), a China based innovative molecular diagnostics company (SZSE: 300685), today announces that it has entered into a Master Collaboration Agreement (Agreement) with AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company.

Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi’s executive team will participate at the Jefferies “Biotech on the Bay” Summit.

The increasing presence of vast telemedicine providers is projected to add a boost to the growth of the global telemedicine market.

DUBAI, United Arab Emirates, Advanced prescription delivery systems have not only assisted in providing round-the-clock customer services but also helped manage dosage, therapy adherence and provide feedback to clinicians.

DUBAI, United Arab Emirates, The mortuary bags market was worth US$ 375.64 Mn in 2021 and is predicted to increase at a CAGR of 4.83% in the next years to US$ 498.62 Mn by 2027.

Albany NY, United States: According to the report, the global disposable syringes market was valued at US$ 6.9 Bn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period from 2020 to 2030.